MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilding, T. J.
Right arrow Articles by Huettner, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilding, T. J.
Right arrow Articles by Huettner, J. E.

Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines

TJ Wilding and JE Huettner

Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110.

Whole-cell recordings were used to study the antagonism of alpha-amino- 3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-preferring and kainate-preferring receptors by 2,3-benzodiazepines. Current through kainate-preferring receptors was recorded in rat dorsal root ganglion (DRG) neuron-s, whereas AMPA receptor current was measured in cultured neurons from rat cerebral cortex. In both cell types 2,3- benzodiazepines produced noncompetitive inhibition; however, antagonist potency was much higher against AMPA-preferring receptors than against kainate receptors. The most potent compound, 1-(4-aminophenyl)-3- methylcarbamyl-4-methyl-7,8- methylenedioxy-3,4-dihydro-5H-2,3- benzodiazepine (GYKI 53655), blocked AMPA receptor currents with an IC50 of approximately 1 microM. A second benzodiazepine, 1-(4- aminophenyl)-4-methyl-7,8- methylenedioxy-5H-2,3-benzodiazepine (GYKI 52466), was about 20-fold less potent at AMPA receptors (IC50 = 18 microM). Both drugs were markedly weaker against kainate currents in DRG neurons. At 200 microM, the highest concentration tested, GYKI 53655 and GYKI 52466 produced only 30-40% inhibition in DRG cells, suggesting that for both compounds the IC50 against kainate receptors is > 200 microM. Our study suggests that GYKI 53655, at a concentration of approximately 10 microM, should produce > 90% block of AMPA- preferring receptors but < 5% inhibition of kainate-preferring receptors. Because the antagonism by this drug is noncompetitive, its effectiveness should not be influenced by phasic changes in transmitter concentration, making it an ideal compound for functional studies of the role of kainate and AMPA receptors in synaptic transmission.

Volume 47, Issue 3, pp. 582-587, 03/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Neurosci.Home page
T. A. Vander Jagt, J. A. Connor, and C. W. Shuttleworth
Localized Loss of Ca2+ Homeostasis in Neuronal Dendrites Is a Downstream Consequence of Metabolic Compromise during Extended NMDA Exposures
J. Neurosci., May 7, 2008; 28(19): 5029 - 5039.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
F. Crepel and H. Daniel
Developmental Changes in Agonist-Induced Retrograde Signaling at Parallel Fiber Purkinje Cell Synapses: Role of Calcium-Induced Calcium Release
J Neurophysiol, November 1, 2007; 98(5): 2550 - 2565.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Vigh and H. von Gersdorff
Prolonged Reciprocal Signaling via NMDA and GABA Receptors at a Retinal Ribbon Synapse
J. Neurosci., December 7, 2005; 25(49): 11412 - 11423.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Hamann, D. J. Rossi, C. Mohr, A. L. Andrade, and D. Attwell
The electrical response of cerebellar Purkinje neurons to simulated ischaemia
Brain, October 1, 2005; 128(10): 2408 - 2420.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
L.-J. Wu, M.-G. Zhao, H. Toyoda, S. W. Ko, and M. Zhuo
Kainate Receptor-Mediated Synaptic Transmission in the Adult Anterior Cingulate Cortex
J Neurophysiol, September 1, 2005; 94(3): 1805 - 1813.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
F. Maingret, S. E Lauri, T. Taira, and J. T. R Isaac
Profound regulation of neonatal CA1 rat hippocampal GABAergic transmission by functionally distinct kainate receptor populations
J. Physiol., August 15, 2005; 567(1): 131 - 142.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Ko, M.-G. Zhao, H. Toyoda, C.-S. Qiu, and M. Zhuo
Altered Behavioral Responses to Noxious Stimuli and Fear in Glutamate Receptor 5 (GluR5)- or GluR6-Deficient Mice
J. Neurosci., January 26, 2005; 25(4): 977 - 984.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. K. Christensen, A. V. Paternain, S. Selak, P. K. Ahring, and J. Lerma
A Mosaic of Functional Kainate Receptors in Hippocampal Interneurons
J. Neurosci., October 13, 2004; 24(41): 8986 - 8993.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. Seifert, K. Huttmann, J. Schramm, and C. Steinhauser
Enhanced Relative Expression of Glutamate Receptor 1 Flip AMPA Receptor Subunits in Hippocampal Astrocytes of Epilepsy Patients with Ammon's Horn Sclerosis
J. Neurosci., February 25, 2004; 24(8): 1996 - 2003.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. S. Gryder and M. A. Rogawski
Selective Antagonism of GluR5 Kainate-Receptor-Mediated Synaptic Currents by Topiramate in Rat Basolateral Amygdala Neurons
J. Neurosci., August 6, 2003; 23(18): 7069 - 7074.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Feng, P. Molnar, and J. V. Nadler
Short-Term Frequency-Dependent Plasticity at Recurrent Mossy Fiber Synapses of the Epileptic Brain
J. Neurosci., June 15, 2003; 23(12): 5381 - 5390.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. F. M. Braga, V. Aroniadou-Anderjaska, J. Xie, and H. Li
Bidirectional Modulation of GABA Release by Presynaptic Glutamate Receptor 5 Kainate Receptors in the Basolateral Amygdala
J. Neurosci., January 15, 2003; 23(2): 442 - 452.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. A. Kerchner, T. J. Wilding, J. E. Huettner, and M. Zhuo
Kainate Receptor Subunits Underlying Presynaptic Regulation of Transmitter Release in the Dorsal Horn
J. Neurosci., September 15, 2002; 22(18): 8010 - 8017.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. Lerma, A. V. Paternain, A. Rodriguez-Moreno, and J. C. Lopez-Garcia
Molecular Physiology of Kainate Receptors
Physiol Rev, July 1, 2001; 81(3): 971 - 998.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Frerking, D. Schmitz, Q. Zhou, J. Johansen, and R. A. Nicoll
Kainate Receptors Depress Excitatory Synaptic Transmission at CA3{right-arrow}CA1 Synapses in the Hippocampus via a Direct Presynaptic Action
J. Neurosci., May 1, 2001; 21(9): 2958 - 2966.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
F. S. Menniti, B. L. Chenard, M. B. Collins, M. F. Ducat, M. L. Elliott, F. E. Ewing, J. I. Huang, K. A. Kelly, J. T. Lazzaro, M. J. Pagnozzi, et al.
Characterization of the Binding Site for a Novel Class of Noncompetitive alpha -Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor Antagonists
Mol. Pharmacol., April 13, 2001; 58(6): 1310 - 1317.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. Bureau, S. Dieudonne, F. Coussen, and C. Mulle
Kainate receptor-mediated synaptic currents in cerebellar Golgi cells are not shaped by diffusion of glutamate
PNAS, June 6, 2000; 97(12): 6838 - 6843.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Rodriguez-Moreno, J. C. Lopez-Garcia, and J. Lerma
Two populations of kainate receptors with separate signaling mechanisms in hippocampal interneurons
PNAS, February 1, 2000; 97(3): 1293 - 1298.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. S. Engelman, T. B. Allen, and A. B. MacDermott
The Distribution of Neurons Expressing Calcium-Permeable AMPA Receptors in the Superficial Laminae of the Spinal Cord Dorsal Horn
J. Neurosci., March 15, 1999; 19(6): 2081 - 2089.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. Dingledine, K. Borges, D. Bowie, and S. F. Traynelis
The Glutamate Receptor Ion Channels
Pharmacol. Rev., March 1, 1999; 51(1): 7 - 62.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. Bureau, S. Bischoff, S. F. Heinemann, and C. Mulle
Kainate Receptor-Mediated Responses in the CA1 Field of Wild-Type and GluR6-Deficient Mice
J. Neurosci., January 15, 1999; 19(2): 653 - 663.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. Wahl, C. Anker, S. F. Traynelis, J. Egebjerg, J. S. Rasmussen, P. Krogsgaard-Larsen, and U. Madsen
Antagonist Properties of a Phosphono Isoxazole Amino Acid at Glutamate R1-4 (R,S)-2-Amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic Acid Receptor Subtypes
Mol. Pharmacol., March 1, 1998; 53(3): 590 - 596.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
T. J. Wilding and J. E. Huettner
Activation and Desensitization of Hippocampal Kainate Receptors
J. Neurosci., April 15, 1997; 17(8): 2713 - 2721.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
P. D. Lukasiewicz, J. A. Wilson, and J. E. Lawrence
AMPA-Preferring Receptors Mediate Excitatory Synaptic Inputs to Retinal Ganglion Cells
J Neurophysiol, January 1, 1997; 77(1): 57 - 64.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L.-M. Zhou, Z.-Q. Gu, A. M. Costa, K. A. Yamada, P. E. Mansson, T. Giordano, P. Skolnick, and K. A. Jones
(2S,4R)-4-Methylglutamic Acid (SYM 2081): A Selective, High-Affinity Ligand for Kainate Receptors
J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 422 - 427.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1995 by the American Society for Pharmacology and Experimental Therapeutics